Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Onco TCS slated to enter phase II

May 3, 1996

AG-2034 data reported at AACR

May 3, 1996

Matrix presents improved formulation of vinblastine

May 3, 1996

Antitumor nucleosides disclosed by Yamasa Shoyu

May 3, 1996

GBC590 progresses to toxicity testing

April 26, 1996

Taisho isolates FD-594 from Streptoverticillium

April 26, 1996

Repligen terminates rPF4 development agreement

April 26, 1996

Antiandrogen research at Roussel Uclaf

April 26, 1996

Topotecan approval recommended

April 26, 1996

MitoExtra enters clinical trials

April 26, 1996

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 13, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...